Impacts
By leading innovation to expand access to life-saving medical products and support the work of healthcare professionals
GlycoBAR contributes to the achievement of the United Nations Sustainable Development Goals (SDGs). The main impacts are the following:
-
Fighting the world’s organ shortages
Enhancing the world’s plasma & platelets supply
Universal plasma & platelets
Means less risk of error, easier logistics, fewer discarded products (Rate of discarded products: 10% to 20% in developed countries; Transfusion Medicine Reviews)
– Facilitates the work of health professionals and particularly caregivers. (~300 “near missed” /year in the UK only; 2021 Annual SHOT Report)
– Improves plasma availability (Helps increase access for the most vulnerable and fight serious diseases (sickle cell disease, anemia, thalassemia, etc.); WHO Global Database on Blood Safety)
Unlocking the potential of immunoglobulin
Develop new treatments with IgM. Advancing IVIG therapy by eliminating hemolysis accidents during massive injections of ungrouped IVIG in immunocompromised patients
(More than 500 critical accidents/year in the US only; Journal of Clinical Apheresis)